Results 101 to 110 of about 10,211 (187)

Immune suppression, HLA-risk and potential future immune based targets of oral leukoplakia progression. [PDF]

Front Dent Med
Soni M, DeSantis B, Villa A, Kamoun M, Gates J.   +4 more
europepmc   +1 more source

Oral leukoplakia: still an enigmatic disorder. [PDF]

Med Oral Patol Oral Cir Bucal
Aguirre-Urizar JM.
europepmc   +1 more source

Cancer Hallmarks Expression in Oral Leukoplakia: Systematic Review and Meta-Analysis. [PDF]

Oral Dis
González-Ruiz I, Ramos-García P, Boujemaoui-Boulaghmoudi H, Mjouel-Boutaleb N, González-Moles MA.   +4 more
europepmc   +1 more source

Histological Morphometry of the Oral Mucosa in Patients with Leukoplakia with Epithelial Dysplasia

Revista Finlay
Foundation: oral leukoplakia is one of the most common potentially malignant disorders worldwide. The study of the histopathological changes in oral leukoplakia is supported by the use of microscopic morphometry.
Yamilka Mesa González, Galia Ivis Pérez Rumbaut, Laura Naranjo Hernández, Grey Alicia Crespo Lechuga, Zuria Ayala Reina, Yisel Alonso Vila Yisel Alonso Vila   +5 more
doaj  

Dual activation of cuproptosis and excessive autophagy by copper-bismuth metal-organic frameworks-loaded detachable microneedles in oral leukoplakia. [PDF]

Mater Today Bio
Zhou K, Gao M, Wan Y, Cong B, Zhu T, Ye Z, Zhang T, Wang W.   +7 more
europepmc   +1 more source

Descriptive transcriptomic profiling differentiates oral leukoplakia from proliferative verrucous leukoplakia and reveals distinct molecular signatures. [PDF]

Med Oral Patol Oral Cir Bucal
Pérez-Sayáns M, Vieira-E-Silva FF, Fernández-Rozadilla C, Carracedo Á, Carlés-González S, Lorenzo-Pouso AI, Pérez-Jardón A, Gándara-Vila P, García-García A, Suárez-Peñaranda JM, Blanco-Carrión A, Chamorro-Petronacci CM.   +11 more
europepmc   +1 more source

Randomized Controlled Trials for Oral Leukoplakia. [PDF]

Oral Dis
Lodolo M, Lodolo M, Valor J, Villa A.
europepmc   +1 more source

Assessment of Promoter Hypermethylation in Tumor Suppressor Genes in Oral Leukoplakia and Oral Submucous Fibrosis. [PDF]

J Pharm Bioallied Sci
Abdul NS, Mhaske S, Afroz S, Nigam S, Jyoti B, Singaraju S, Shivakumar S, Channaiah SG.   +7 more
europepmc   +1 more source

Azoxystrobin induces mitochondrial dysfunction and mitochondrial pathway apoptosis by targeting the Prx1 Trp87 and Thr90 sites in oral leukoplakia. [PDF]

Front Pharmacol
Li W, Shen Y, Li L, Wang M, Zhang M, Tang X.   +5 more
europepmc   +1 more source

Migrasome-transported PTGES amplifies the PGE2 cascade in SPP1⁺ macrophages to drive oral leukoplakia carcinogenesis. [PDF]

Nat Commun
Jiang MJ, Zhou HY, Bai YT, Chen XJ, Zhou G.   +4 more
europepmc   +1 more source